National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.
Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis.
Drug utilization patterns and adherence in patients on systemic medications for the treatment of psoriasis: A retrospective, comparative cohort study
Navigating iPLEDGE enrollment for transgender and gender-diverse patients: a guide for providing culturally competent care
The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials.
Counterpoint: A tale of two meta-analyses revisited...J Am Acad Dermatol. 2013 May;68(5):863-5; J Am Acad Dermatol. 2014 Feb;70(2):380-1